J. Genescà
0000-0002-0831-8422
12 papers found
Refreshing results…
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and cons
<p>Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory</p>
Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers
Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation
Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis
Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis
Missing publications? Search for publications with a matching author name.